免疫治疗靶向脑胶质瘤肿瘤干细胞。
Immune therapeutic targeting of glioma cancer stem cells.
机构信息
Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Unit 442, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA.
出版信息
Target Oncol. 2010 Sep;5(3):217-27. doi: 10.1007/s11523-010-0151-8. Epub 2010 Aug 25.
Abstract
Glioblastoma multiforme (GBM) is a lethal cancer that responds poorly to radiotherapy and chemotherapy. Glioma cancer stem cells (gCSCs) have been shown to recapitulate the characteristic features of GBM and to mediate chemotherapy and radiation resistance. Immunotherapeutic targeting of this cell population holds therapeutic promise but must be considered in the context of the immunosuppressive properties mediated by the gCSC. Recent findings have indicated that this goal will be challenging because the gCSC can suppress both the innate and adaptive immune systems by a variety of gCSC-secreted products and cell-membrane interactions. In this review article, we will attempt to reconcile the disparate research findings regarding the potential of immune targeting of the gCSC and propose several novel solutions.
摘要
多形性胶质母细胞瘤（GBM）是一种致命的癌症，对放疗和化疗反应不佳。已经表明，神经胶质瘤癌症干细胞（gCSC）能够重现 GBM 的特征，并介导化疗和辐射抵抗。针对该细胞群体的免疫治疗具有治疗潜力，但必须考虑到 gCSC 介导的免疫抑制特性。最近的研究结果表明，这一目标具有挑战性，因为 gCSC 可以通过各种 gCSC 分泌产物和细胞膜相互作用来抑制固有和适应性免疫系统。在这篇综述文章中，我们将尝试调和关于免疫靶向 gCSC 的潜力的不同研究结果，并提出几种新的解决方案。
相似文献
1
Immune therapeutic targeting of glioma cancer stem cells.免疫治疗靶向脑胶质瘤肿瘤干细胞。
Target Oncol. 2010 Sep;5(3):217-27. doi: 10.1007/s11523-010-0151-8. Epub 2010 Aug 25.
2
Glioma cancer stem cells induce immunosuppressive macrophages/microglia.胶质母细胞瘤肿瘤干细胞诱导免疫抑制性巨噬细胞/小胶质细胞。
Neuro Oncol. 2010 Nov;12(11):1113-25. doi: 10.1093/neuonc/noq082. Epub 2010 Jul 28.
3
Hypoxia potentiates glioma-mediated immunosuppression.缺氧增强了胶质瘤介导的免疫抑制。
PLoS One. 2011 Jan 20;6(1):e16195. doi: 10.1371/journal.pone.0016195.
4
Immunobiology and immunotherapeutic targeting of glioma stem cells.胶质瘤干细胞的免疫生物学与免疫治疗靶向
Adv Exp Med Biol. 2015;853:139-66. doi: 10.1007/978-3-319-16537-0_8.
5
Frontiers in targeting glioma stem cells.靶向神经胶质瘤干细胞的研究前沿。
Eur J Cancer. 2011 Mar;47(4):496-507. doi: 10.1016/j.ejca.2010.11.017. Epub 2010 Dec 22.
6
Immunotherapy targeting glioma stem cells--insights and perspectives.针对神经胶质瘤干细胞的免疫疗法——见解与展望。
Expert Opin Biol Ther. 2012 Feb;12(2):165-78. doi: 10.1517/14712598.2012.648180. Epub 2011 Dec 26.
7
Glioblastoma stem cells and stem cell-targeting immunotherapies.胶质母细胞瘤干细胞与靶向干细胞的免疫疗法
J Neurooncol. 2015 Jul;123(3):449-57. doi: 10.1007/s11060-015-1729-x. Epub 2015 Feb 15.
8
Immunotherapies for malignant glioma.恶性脑胶质瘤的免疫治疗。
Oncogene. 2018 Mar;37(9):1121-1141. doi: 10.1038/s41388-017-0024-z. Epub 2017 Dec 15.
9
Cell- and peptide-based immunotherapeutic approaches for glioma.基于细胞和肽的神经胶质瘤免疫治疗方法。
Trends Mol Med. 2008 May;14(5):228-35. doi: 10.1016/j.molmed.2008.03.003. Epub 2008 Apr 9.
10
Glioma stem cell research for the development of immunotherapy.胶质瘤干细胞研究用于免疫疗法的开发。
Adv Exp Med Biol. 2012;746:216-25. doi: 10.1007/978-1-4614-3146-6_17.
引用本文的文献
1
Current approaches in glioblastoma multiforme immunotherapy.胶质母细胞瘤的免疫治疗现状。
Clin Transl Oncol. 2024 Jul;26(7):1584-1612. doi: 10.1007/s12094-024-03395-7. Epub 2024 Mar 21.
2
Multifaceted WNT Signaling at the Crossroads Between Epithelial-Mesenchymal Transition and Autophagy in Glioblastoma.胶质母细胞瘤中上皮-间质转化与自噬交叉点上的多面WNT信号传导
Front Oncol. 2020 Nov 12;10:597743. doi: 10.3389/fonc.2020.597743. eCollection 2020.
3
Extracellular Vesicle lncRNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 Released From Glioma Stem Cells Modulates the Inflammatory Response of Microglia After Lipopolysaccharide Stimulation Through Regulating miR-129-5p/High Mobility Group Box-1 Protein Axis.外泌体 lncRNA 转移相关肺腺癌转录本 1 由神经胶质瘤干细胞释放，通过调节 miR-129-5p/高迁移率族蛋白 1 蛋白轴调节脂多糖刺激后小胶质细胞的炎症反应。
Front Immunol. 2020 Feb 7;10:3161. doi: 10.3389/fimmu.2019.03161. eCollection 2019.
4
Glioblastoma Stem Cells and Comparison of Isolation Methods.胶质母细胞瘤干细胞及分离方法比较
J Clin Med Res. 2019 Jun;11(6):415-421. doi: 10.14740/jocmr3781. Epub 2019 May 10.
5
The role of cancer stem cells in the modulation of anti-tumor immune responses.肿瘤干细胞在抗肿瘤免疫反应调节中的作用。
Semin Cancer Biol. 2018 Dec;53:189-200. doi: 10.1016/j.semcancer.2018.09.006. Epub 2018 Sep 24.
6
Systemic T Cells Immunosuppression of Glioma Stem Cell-Derived Exosomes Is Mediated by Monocytic Myeloid-Derived Suppressor Cells.胶质瘤干细胞衍生外泌体的全身T细胞免疫抑制由单核细胞来源的髓系抑制细胞介导。
PLoS One. 2017 Jan 20;12(1):e0169932. doi: 10.1371/journal.pone.0169932. eCollection 2017.
7
Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients.巨细胞病毒是小儿胶质母细胞瘤的一个靶点吗？一组小儿胶质母细胞瘤患者中巨细胞病毒蛋白pp65和IE1-72以及巨细胞病毒核酸的表达情况。
J Neurooncol. 2015 Nov;125(2):307-15. doi: 10.1007/s11060-015-1905-z. Epub 2015 Sep 4.
8
Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme.基于树突状细胞的多形性胶质母细胞瘤免疫治疗
Biomed Res Int. 2015;2015:717530. doi: 10.1155/2015/717530. Epub 2015 Jun 17.
9
Engulfing losers by winners in cancer: do cancer stem cells catch eat-me signals from noncancer stem cells?癌症中胜者吞噬失败者：癌症干细胞会捕捉来自非癌症干细胞的“自我吞噬”信号吗？
Future Oncol. 2014 Jun;10(8):1335-8. doi: 10.2217/fon.14.66.
10
Mouse glioma immunotherapy mediated by A2B5+ GL261 cell lysate-pulsed dendritic cells.A2B5+ GL261 细胞裂解物脉冲树突状细胞介导的小鼠脑胶质瘤免疫治疗。
J Neurooncol. 2014 Feb;116(3):497-504. doi: 10.1007/s11060-013-1334-9. Epub 2014 Jan 8.
本文引用的文献
1
Glioma cancer stem cells induce immunosuppressive macrophages/microglia.胶质母细胞瘤肿瘤干细胞诱导免疫抑制性巨噬细胞/小胶质细胞。
Neuro Oncol. 2010 Nov;12(11):1113-25. doi: 10.1093/neuonc/noq082. Epub 2010 Jul 28.
2
A multigene predictor of outcome in glioblastoma.胶质母细胞瘤的多基因预后预测指标。
Neuro Oncol. 2010 Jan;12(1):49-57. doi: 10.1093/neuonc/nop007. Epub 2009 Oct 20.
3
Hypoxia inducible factors in cancer stem cells.缺氧诱导因子在肿瘤干细胞中的作用。
Br J Cancer. 2010 Mar 2;102(5):789-95. doi: 10.1038/sj.bjc.6605551. Epub 2010 Jan 26.
4
Nuclear factor-kappaB and tumor-associated macrophages.核因子-κB 与肿瘤相关巨噬细胞。
Clin Cancer Res. 2010 Feb 1;16(3):784-9. doi: 10.1158/1078-0432.CCR-09-1015. Epub 2010 Jan 26.
5
Immunobiological characterization of cancer stem cells isolated from glioblastoma patients.从胶质母细胞瘤患者中分离出的肿瘤干细胞的免疫生物学特性。
Clin Cancer Res. 2010 Feb 1;16(3):800-13. doi: 10.1158/1078-0432.CCR-09-2730. Epub 2010 Jan 26.
6
Glioma-associated cancer-initiating cells induce immunosuppression.胶质母细胞瘤相关的癌症起始细胞可诱导免疫抑制。
Clin Cancer Res. 2010 Jan 15;16(2):461-73. doi: 10.1158/1078-0432.CCR-09-1983. Epub 2010 Jan 12.
7
Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway.胶质母细胞瘤起始细胞通过信号转导和转录激活因子 3 通路抑制 T 细胞增殖和效应器反应。
Mol Cancer Ther. 2010 Jan;9(1):67-78. doi: 10.1158/1535-7163.MCT-09-0734. Epub 2010 Jan 6.
8
Antibodies targeting cancer stem cells: a new paradigm in immunotherapy?针对癌症干细胞的抗体：免疫治疗的新模式？
MAbs. 2009 Jan-Feb;1(1):12-25. doi: 10.4161/mabs.1.1.7347.
9
The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors.JAK2抑制剂AZD1480可有效阻断实体瘤中的Stat3信号传导和肿瘤发生。
Cancer Cell. 2009 Dec 8;16(6):487-97. doi: 10.1016/j.ccr.2009.10.015.
10
Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.CD8 + 细胞毒性T细胞对脑肿瘤干细胞样起始细胞的识别与杀伤
Cancer Res. 2009 Dec 1;69(23):8886-93. doi: 10.1158/0008-5472.CAN-09-2687. Epub 2009 Nov 10.
Zotero 插件